1 / 48

LEPROSY

LEPROSY. HANSEN’S DISEASE DISCOVERED THE ORGANISM IN 1874 CHRONIC INFECTIOUS DISEASE AFFECTING THE COOLER PARTS OF THE BODY. LEPROSY. EXAMPLE SKIN ,MOUTH,RESPIRATORY TRACT,EYES, PERIPHERAL NERVES,SUPERFICIAL LYMPH NODES & TESTIS. LEPROSY.

hmedley
Download Presentation

LEPROSY

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. LEPROSY HANSEN’S DISEASE DISCOVERED THE ORGANISM IN 1874 CHRONIC INFECTIOUS DISEASE AFFECTING THE COOLER PARTS OF THE BODY

  2. LEPROSY EXAMPLE SKIN ,MOUTH,RESPIRATORY TRACT,EYES, PERIPHERAL NERVES,SUPERFICIAL LYMPH NODES & TESTIS.

  3. LEPROSY BACTERAEMIA FROM ENDOTHELIAL COLONISATION OR BY BACILLI FILTERED FROM BLOOD BY RE SYSTEM, OTHER ORGANS SUCH AS LIVER,SPLEEN ,BONE MARROW & REGIONAL LYMPH NODES ARE ALSO INVOLVED

  4. LEPROSY CAUSATIVE ORGANISM MYCOBACTERIUM LEPRAE LESS ACID-FAST THAN M.TUBERCULOSIS 1. ZIEHL-NEELSEN STAINING –DECOLOURISED BY 5% SULPHURIC ACID 2. FITE – FARACO STAINING 3.GOMORI METHENAMINE SILVER

  5. SLIT SKIN SMEAR TECHNIQUE GIVES QUANTITATIVE MEASURE OF M.LEPRAE STAINED WITH ZIEHL NEELSEN METHOD EXAMINED UNDER 100 x - OIL IMMERSION OBJECTIVE TO DETERMINE THE DENSITY OF ORGANISM IN THE LESION

  6. SLIT SMEAR TECHNIQUE BACTERIAL INDEX –SCORED FROM 1+ TO 6 RANGE FROM 1 TO 10 BACILLI PER 100 FIELDS TO MORE THAN 1000 PER FIELD AS MULTIBACILLARY LEPROSY BI – 0 IS TERMED - PAUSI -BACILLARY

  7. INCIDENCE OF LEPROSY ENDEMIC IN AREAS WITH HOT & MOIST CLIMATES & IN POOR TROPICAL COUNTRIES FIVE COUNTRIES- INDIA,BRAZIL,INDONESIA,MYANMAR & NIGERIA VAST MAJORITY OF CASES INDIA –ONE THIRD OF ALL REGISTERED CASES

  8. INCIDENCE OF LEPROSY

  9. INCIDENCE OF LEPROSY

  10. INCIDENCE OF LEPROSY IN INDIA – TAMILNADU,BIHAR,PONDICHERRY,AND ANDHRA PRADESH,ORISSA ,WEST BENGAL & ASSAM

  11. MODE OF TRANSMISSION SLOW COMMUNICABLE DISEASE THE INCUBATION PERIOD BETWEEN FIRST EXPOSURE & APPEARANCE OF SIGNS & SYMPTOMS OF DISEASE VARIES FROM 2 – 20 YEARS

  12. MODE OF TRANSMISSION 1.DIRECT CONTACT 2. MATERNOFETAL TRANSMISSION 3.MOTHER’S MILK

  13. CLASSIFICATION OF LEPROSY(RIDLEY JOPLING’S) SEVEN GROUPS TT –TUBERCULOID POLAR(HIGH RESISTANCE) BT- BORDERLINE TUBERCULOID TI – TUBERCULOID INDEFINITE BB –MID BORDERLINE LI- LEPROMATOUS INDEFINITE

  14. CLASSIFICATION OF LEPROSY(RIDLEY JOPLING’S) BL - BORDERLINE LEPROMATOUS LL- LEPROMATOUS POLAR

  15. CLINICAL FEATURES OF LEPROSY 2 MAIN FORMS SHOW DISTINCTIVE FEATURES 1.LEPROMATOUS LEPROSY – SKIN LESIONS ARE SYMMETRIC ,MULTIPLE ,SLIGHTLY HYPOPIGMENTED,ERYTHEMATOUS MACULES,PAPULES,NODULES

  16. LEPROMATOUS LEPROSY

  17. CLINICAL FEATURES OF LEPROSY NODULAR LESIONS MAY COALESCE TO GIVE A LEONINE FACIES APPEARANCE LESIONS ARE HYPOAESTHETIC OR ANAESTHETIC BUT SENSORY DISTERBANCE IS NOT DISTINCT AS IN TUBERCULOID LEPROSY

  18. CLINICAL FEATURES OF LEPROSY TUBERCULOID LEPROSY SINGLE OR FEW ASYMMETRIC LESIONS & ARE HYPOPIGMENTED & ERYTHEMATOUS MACULES THERE IS DISTINCT SENSORY IMPAIRMENT

  19. TUBERCULOID LEPROSY

  20. HISTOPATHOLOGY OF LEPROSY GUIDELINES 1. CELL TYPE GRANULOMA 2. NERVE INVOLVEMENT 3. BACTERIAL LOAD

  21. HISTOPATHOLOGY OF LEPROSYLEPROMATOUS LEPROSY LEPROMATOUS LEPROSY DERMIS – PROLIFERATION OF MACROPHAGES WITH FOAMY CYTOPLASM,SEEN AROUND THE BLOOD VESSELS,NERVES &DERMAL APPENDAGES

  22. HISTOPATHOLOGY OF LEPROSYLEPROMATOUS LEPROSY AFB STAIN – BACILLI IN GLOBULAR MASSES OR IN PARALLEL FASHION LIKE CIGARETTES IN PACK IN THE FOAMY MACROPHAGES (LEPRA CELLS OR VIRCHOW CELLS)

  23. AFB STAIN

  24. HISTOPATHOLOGY OF LEPROSYLEPROMATOUS LEPROSY CLEAR ZONE BETWEEN THE EPIDERMIS & THE INFILTRATE IN THE DERMIS EPIDERMIS OVERLYING THE LESIONS IS THINNED OUT ,MAY EVEN ULCERATE

  25. TUBERCULOID LEPROSY

  26. TUBERCULOID LEPROSY

  27. HISTOPATHOLOGY OF LEPROSYTUBERCULOID LEPROSY POLAR TUBERCULOID FORM TUBERCLES COMPOSED OF EPITHELOID CELLS,LANGHANS TYPE OF GIANT CELLS &PERIPHERAL MANTLE OF LYMPHOCYTES

  28. HISTOPATHOLOGY OF LEPROSYTUBERCULOID LEPROSY INFILTRATE HAS PREDILECTION FOR DERMAL NERVES WITH GRANULOMAS & DESTRUCTION OF NERVES NO CLEAR ZONE

  29. 3. BORDERLINE LEPROSY 1.BORDERLINE TUBERCULOID(BT) EPITHELOID CELLS, PLENTY OF LYMPHOCYTES NARROW CLEAR ZONE BACILLI ARE FEW & ARE FOUND IN NERVES

  30. 3. BORDERLINE LEPROSY 2. BORDERLINE LEPROMATOUS PREDOMINANCE OF HISTIOCYTES,FEW EPITHELOID CELLS.SOME IRREGULARLY DISPERSED LYMPHOCYTES NUMEROUS LEPRA BACILLI ARE SEEN

  31. 3. BORDERLINE LEPROSY 3.MID BORDERLINE(BB) EPITHELOID CELLS NO GIANT CELLS SOME LYMPHOCYTES IN THE PERINEURIUM LEPRA BACILLI IN THE NERVES

  32. 4.INDETERMINATE LEPROSY NONSPECIFIC CHRONIC DERMATITIS LIKE BUT FOLLOWING FEATURES HELP IN DIAGNOSIS a. LYMPHOCTIC OR MONONUCLEAR CELL INFILTRATE AROUND SKIN ADNEXAL STRUCTURES LIKE HAIR FOLLICLES

  33. 4.INDETERMINATE LEPROSY b.NERVE INVOLVEMENT c. AFB STAIN

  34. REACTIONS IN LEPROSY 2 TYPES 1.TYPE 1 – BORDERLINE REACTIONS 2.TYPE II – ERYTHEMA NODOSUM LEPROSUM

  35. TYPE I REACTION POLAR FORMS OF LEPROSY DO NOT UNDERGO CHANGE IN CLINICAL OR HISTOPATHOLOGICAL PICTURE

  36. TYPE I REACTION OCCURS IN PATIENT’S WITH BORDERLINE LEPROMATOUS LEPROSY(BL) ON TREATMENT. UPGRADE OR SHIFT TOWARDS TUBERCULOID TYPE

  37. TYPE I REACTION THE BORDERLINE GROUPS ARE UNSTABLE & MAY MOVE ACROSS THE SPECTRUM IN EITHER DIRECTIONS WITH UPGRADING & DOWNGRADING OF PATIENT’S IMMUNE STATUS

  38. TYPE I REACTIONUPGRADING REACTION ACCORDINGLY THERE MAY BE 2 TYPES OF BORDERLINE REACTIONS 1. UPGRADING REACTION – CHARACTERISED BY INCREASED CELL MEDIATED IMMUNITY

  39. TYPE I REACTIONUPGRADING REACTION HISTOLOGY - INCREASE OF LYMPHOCYTES OEDEMA REDUCED BACTERIAL INDEX

  40. TYPE I REACTIONDOWNGRADING TYPE 2 .DOWNGRADING REACTION CHARACTERISED BY LOWERING OF CELLULAR IMMUNITY

  41. TYPE I REACTIONDOWNGRADING TYPE SEEN IN BORDERLINE TUBERCULOID TYPE DOWNGRADE OR SHIFT TOWARDS LEPROMATOUS TYPE HISTOLOGY –DISPERSAL OF GRANULOMAS INCREASED NUMBER OF LEPRA CELLS

  42. TYPE II REACTION –ERYTHEMA NODOSUM LEPROSUM OCCURS IN LEPROMATOUS PATIENTS AFTER TREATMENT CHARACTERISED BY TENDER CUTANEOUS NODULES ,FEVER,IRIDOCYCLITIS,SYNOVITIS & LYMPH NODE INVOLVEMENT

  43. TYPE II REACTION –ERYTHEMA NODOSUM LEPROSUM HISTOLOGY - INFILTRATION BY NEUTROPHILS & PROMINENCE OF VASCULITIS SECONDARY AMYLOIDOSIS MAY FOLLOW REPEATED ATTACKS

  44. IMMUNOLOGY OF LEPROSY LEPROMIN TEST –INTRADERMAL INJECTION OF LEPROMIN , AN ANTIGENIC EXTRACT OF M.LEPRAE. NOT A DIAGNOSTIC TEST BUT USED FOR CLASSIFYING LEPROSY ON THE BASIS OF IMMUNE RESPONSE

  45. IMMUNOLOGY OF LEPROSY M.LEPRAE REVEALS DELAYED HYPERSENSITIVITY REACTION (BY T HELPER CELLS) IN PATIENT’S WITH TUBERCULOID LEPROSY

  46. IMMUNOLOGY OF LEPROSY 1.FERNANDEZ REACTION –EARLY POSITIVE REACTION- AS AN INDURATED AREA IN 24- 48 HOURS

  47. IMMUNOLOGY OF LEPROSY 2.MITSUDA REACTION - A DELAYED GRANULOMATOUS LESION AFTER 3 – 4 WEEKS PATIENTS OF LEPROMATOUS LEPROSY ARE NEGATIVE BY THE LEPROMIN TEST

  48. IMMUNOLOGY OF LEPROSY LL LACK T HELPER CELLS BUT LL HAVE HIGH LEVELS OF IMMUNOGLOBULINS LIKE IgG,IgA,IgM & ANTIBODIES TO MYCOBACTERIAL ANTIGENS

More Related